Skip to main content
HairCited

Hierro para Telogen Effluvium

B

Basado en 56 estudios (2 RCTs) con 11,067 participantes en total. Los resultados son variados entre los estudios.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusión

Iron may support recovery from telogen effluvium, particularly when low ferritin levels are confirmed, but the evidence is mixed and routine supplementation without testing is not well-supported.

  • 56 studies provide substantial evidence, though results are mixed across the research
  • Lower ferritin levels are commonly found in patients with telogen effluvium
  • One study found iron supplementation improved satisfaction even in patients without overtly low ferritin
  • Blood testing for ferritin and iron levels is recommended before starting supplementation

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Efecto: None None

Población: women with androgenetic alopecia (female pattern hair loss)

scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Efecto: None None
Retrospective cohort n=2851
Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience.
Dose: None vs: Placebo Efecto: Ferritin low in 46.5% of patients; iron deficiency in 29.5% p<0.05
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs: Placebo Efecto: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None

Key Statistics

62

Estudios

11072

Participantes

Mixed

B

Calificación

Referenced Papers

Journal of drugs … 2021 3 citas
Acta dermatovenerologica Croatica … 2016 6 citas
Journal of clinical … 2015 190 citas
Clinical obstetrics and … 2015 9 citas
Turkish journal of … 2014 5 citas
Annals of gastroenterology 2014 5 citas
Seminars in cutaneous … 2006 23 citas
American journal of … 2005 140 citas
Journal of the … 2005 64 citas
Revue medicale de … 2004
International journal of … 2002 95 citas
Dermatologic clinics 1993 38 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
18 mg/day (women)
deficiency:
65-200 mg elemental iron/day

Límite superior: 45 mg/day

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Neutral --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
None -- Mixed --
None -- Neutral 2851
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
None -- Positive --
not applicable (observational; serum ferritin measured) -- Negative 100
None -- Mixed --

Mejor momento para tomar: On an empty stomach with vitamin C for best absorption; take 2 hours apart from calcium

Safety & Side Effects

Efectos secundarios reportados

  • Constipation (most common)
  • Nausea and stomach cramps
  • Dark or black stools
  • Iron overload with excessive supplementation (hemochromatosis risk)

Interacciones conocidas

  • Calcium supplements and dairy (reduce iron absorption by 50-60%)
  • Proton pump inhibitors (omeprazole) and H2 blockers reduce absorption
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Levothyroxine (iron reduces thyroid hormone absorption)

Ingesta máxima tolerable: 45 mg/day

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Hierro help with Telogen Effluvium?
Based on 62 studies with 11,072 participants, there is moderate evidence from clinical studies that Hierro may support Telogen Effluvium management. Our evidence grade is B (Good Evidence).
How much Hierro should I take for Telogen Effluvium?
Studies have used various dosages. A commonly studied range is 18 mg/day (women). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Hierro?
Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Hierro and Telogen Effluvium?
We rate the evidence as Grade B (Good Evidence). This rating is based on 62 peer-reviewed studies with 11,072 total participants. The overall direction of effect is mixed.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.